| Aggressive B-Cell Non-Hodgkin Lymphoma investigated in trials for …INVESTIGATED_IN_TRIALSderived108 of 108show fewer |
|---|
| → investigated in trials for | Cyclophosphamidesmall molecule 84 trials (30 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 84 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 82 trials (22 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 82 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 45 trials (16 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 45 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 44 trials (13 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 44 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 44 trials (11 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 44 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 40 trials (19 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 40 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 39 trials (15 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 39 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 26 trials (11 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 23 trials (9 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 22 trials (7 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 16 trials (6 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 16 trials (9 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 16 trials (11 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 15 trials (3 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 13 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 13 trials (4 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 12 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 10 trials (3 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall molecule 10 trials (7 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epcoritamabmonoclonal antibody 9 trials (7 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mosunetuzumabmonoclonal antibody 8 trials (7 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Polatuzumab Vedotinadc 8 trials (6 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Inotuzumab Ozogamicinadc 7 trials (5 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mercaptopurinesmall molecule 7 trials (5 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ofatumumabmonoclonal antibody 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acalabrutinibsmall molecule 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carmustinesmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Blinatumomabmonoclonal antibody 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegaspargaseother 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Clofarabinesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lisocabtagene Maraleucelgene therapy 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tafasitamabmonoclonal antibody 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanubrutinibsmall molecule 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axicabtagene Ciloleucelgene therapy 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Plerixaforsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thioguaninesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Buparlisibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Calaspargase Pegolother 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Glofitamabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Loncastuximab Tesirineadc 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pirtobrutinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisolonesmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tisagenlecleucelcell therapy 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvespimycinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Asparaginaseother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brentuximab Vedotinadc 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daunorubicinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HDAC Inhibitor REC-2282 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HyperCVAD Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idelalisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ixazomibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lomustinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitoxantronesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | O6-Benzylguaninesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obecabtagene Autoleucelgene therapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Odronextamabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pidnarulexsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pomalidomidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Procarbazinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Teniposidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Treosulfansmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valproic Acidsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinblastinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vindesinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Aggressive B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |